The hazard ratios hint at a possible trend i.e., increased risk for EFS, decreased for OS, but the confidence intervals are too wide to draw firm conclusions.
← all excerpts
Clinical and genetic insights into novel TP53 mutations in De Novo AML patients.
1
—
—